FY2024
Effective from
- Inherited rules changed
Amyloidosis
Category — select a more specific code
CDC/NCHS · FY2024Alzheimer's disease (G30.0-)
Ehlers-Danlos syndromes (Q79.6-)
For US diagnosis claims covered by HIPAA, ICD-10-CM is required from October 1, 2015.
Use the service date for outpatient/professional claims and the discharge date for hospital inpatient claims. Earlier encounters use ICD-9-CM; each individual code must also be valid for the applicable date.
Official coding guidelines → · CMS ↗First observed · 2015-10-01
Latest recorded change · FY2024
Effective from
Amyloidosis
Category — select a more specific code
CDC/NCHS · FY2024| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | Code-level rules changed |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | Inherited rules changed |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | Inherited rules changed |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | Inherited rules changed |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | Inherited rules changed |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Alzheimer's disease (G30.0-)
All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Ehlers-Danlos syndromes (Q79.6-)
E85.0Non-neuropathic heredofamilial amyloidosisBillable / specificE85.1Neuropathic heredofamilial amyloidosisBillable / specificE85.2Heredofamilial amyloidosis, unspecifiedBillable / specificE85.3Secondary systemic amyloidosisBillable / specificE85.4Organ-limited amyloidosisBillable / specificE85.8Other amyloidosisCategory · further specificity requiredE85.9Amyloidosis, unspecifiedBillable / specificOfficial titles and instructions are preserved in their source language. Official sources ↗
Code first · amyloidosis (E85.-)
Excludes 1 · amyloidosis (E85.-)
Code first · amyloidosis cerebral degeneration (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · underlying amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Excludes 2 · amyloid degeneration of liver (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Excludes 2 · hereditary amyloid nephropathy (E85.-)
Excludes 2 · non-neuropathic heredofamilial amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Code first · amyloidosis (E85.-)
Excludes 1 · myopathy in amyloidosis (E85.-)